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The effect of atrial contraction on cardiac function is reviewed in patients with dual chamber and rate-responsive
ventricular pacemakers. The question posed was is there any haemodynamic, clinical or prognostic advantage of AV
synchrony in dual chamber pacemakers in comparison to rate-responsive ventricular pacemakers? Optimal A V delay in
dual chamber pacing favours cardiac performance at rest, while during exercise the increase in heart rate rather than
A V synchrony influences cardiac performance and working capacity. However, there is little information on the benefit
of maintained A V synchrony in patients' daily activities. Patients with pacemakers which maintain AV synchrony seem
to have less morbidity and mortality than patients with ventricular stimulation alone, and there are comparable rates of
complication in carriers of single and dual chamber pacemakers, the former showing problems with the pacemaker
syndrome and the latter with atrial sensing and pacemaker-induced tachycardias. The disadvantage of dual chamber
pacemakers are higher costs and time-consuming controls.
Introduction
In comparison with fixed rate ventricular pacing (VVI),
rate-responsive pacemakers (VVIR) may increase car-
diac output and exercise capacity by a rise in heart
rate11 S]. Dual chamber pacemakers (DDD) that sense
the atrial wave, maintain the normal sequence of cardiac
chamber activation (atrioventricular synchrony) and
permit a chronotropic response to exercise in patients
with normal sinoatrial function. During exercise, the
additional atrial contribution to ventricular filling (atrial
'kick') in dual chamber pacing is supposed to improve
haemodynamic function to a greater extent than in
rate-responsive ventricular pacing alone. Any dis-
cussion about the importance of maintained atrio-
ventricular (AV) synchrony has to answer the following:
Is there any haemodynamic, clinical or prognostic
advantage as regards AV synchrony in carriers of
dual chamber pacemakers in comparison with rate-
responsive ventricular pacemakers?
HAEMODYNAMIC ADVANTAGE OF MAINTAINED AV
SYNCHRONY AT REST
Previous studies have shown that atrial contribution
to ventricular filling in hearts with normal left ventricu-
lar function can cause a more than 20% increase in
cardiac output'6 13]. Particularly susceptible to this
improvement are those patients with left ventricular
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hypertrophy114151, those of advanced age1161 or with left
ventricular diastolic dysfunction'17'181. However, contro-
versy exists about patients with impaired left ventricular
systolic function. Several studies proved the value of
AV synchrony in these patients'18 201 but they did not
evaluate the influence of left ventricular filling pressure
on atrial contribution to cardiac output. Greenberg
et a/.'2'1 and Myreng et alP2] found an inverse relation-
ship between ventricular filling pressure and atrial con-
tribution to cardiac output. Faerestrand and Ohm'61,
French et alPi] and Dritsas et a/.'241 found no benefit in
relation to atrial systole in patients with left ventricular
failure. Consequently, most evidence is demonstrated in
hearts with normal ventricular filling pressures. Thus, at
high passive filling pressures the ventricle is maximally
dilated and operates at the extreme of the flattened
Frank-Starling curve. Therefore, a further increase in
preload by the atrial 'kick' does not augment stroke
volume.
Irrespective of the underlying cardiac disease, in order
to maximize cardiac output in patients with dual cham-
ber pacemakers it is essential to have an appropriately
timed atrial contraction prior to the onset of ventricular
systole. The timing of atrial contraction is important in
coordinating AV valve closure, since the major mech-
anism of such a closure is the increase in ventricular
end-diastolic pressure1'81. An inappropriately timed AV
delay may cause mitral regurgjtation and impaired dia-
stolic filling1251. To avoid unnecessary ventricular pacing
and early battery depletion, the AV delay is often
lengthened to achieve an intrinsic ventricular contrac-
tion, but an impaired haemodynamic function has
also been demonstrated in unpaced patients whose PR
intervals are too long126'271.
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Table 1 Optimal A V delay in patients at rest
Reference, Parameters Optimal
year measured AV delay (ms) Remarks
Nitsch1", 1984
Mehta1281, 1989
Iwasel29', 1986
Wish13", 1987
JanosuV32', 1989
Frielingsdorf331, 1994
Sulke1341, 1992
Haskell'351, 1986
Videen13*!, 1986
Dritsas1241, 1993
SV, CO
CO
LVIV
SV
CO
EF
Quality
of life
CO
EF, CI
SV
100-150
150
150
144
144 or 176
150, 200
125, 175 RR
150, 200
140-150
172, 142, 97
200 ms for long interatnal delays
144 ms for VDD, 176 ms for DV1 pacing
150 ms for fast heart rates
190-200 ms for patients with reduced EF
172 ms for diastolic dysfunction, 97 ms
for systolic dysfunction, 142 ms for
normal LV function
AV=atrioventricular, CO=cardiac output, CI=cardiac index, DVI = AV sequential pacing,
EF=ejection fraction, LV = left ventricular, LVlV = left ventricular inflow volume, RR = rate
responsive AV delay, SV=stroke volume, VDD = atrial triggered ventricular pacing.
Even deviations in AV delay, by as little as 25 ms from
an individual's optimal AV delay, resulted in a signifi-
cant decrease in cardiac output'26"28"321. In a study by
our group'33' some patients showed a higher ejection
fraction with single chamber ventricular pacing than
with dual chamber pacing with an inappropriately timed
AV delay (Table 1). Therefore, an inappropriately timed
atrial systole as a result of a dual chamber pacemaker
may be of little or no benefit as regards the haemo-
dynamic effect than a ventricular-inhibited single cham-
ber pacemaker19'131. Little has been reported on the
clinical relevance of optimizing the AV delay. Sulke et
a/.[34) found that short AV delay settings (125 ms,
175 ms) were better tolerated than longer settings
(250 ms) during out-of-hospital activity.
AV delays between 150 to 200 ms produced maximal
left ventricular ejection fraction (Table 1). The optimal
AV delay which makes atrial contraction coincide with
late diastole and thus contribute most to left ventricular
filling1291 is determined by factors such as heart rate128'351,
left ventricular function'24-36^381, atrial size1391 and the
inter-individual variability of the intra-atrial conduction
timeI3.,32.4O]
A shorter or longer intra-atrial conduction time cor-
responds to a shorter or longer AV delay1311. This is of
special clinical relevance when pacing mode changes
from dual chamber sequential (DVI) to atrial triggered
ventricular pacing (VDD) because the left atrial to left
ventricular sequence increases. To avoid a change in
timing of left atrial contraction, with resulting decrease
in stroke volume, the programmed AV delay must be
shorter during atrial-triggered than during dual chamber
sequential stimulation131'32'361. A difference of 30-50 ms
may be necessary to optimize cardiac output'3 li32'411
which emphasizes the importance of the AV delay
hysteresis with altering pacing modes. This plays a
particular role in the sick sinus syndrome which requires
frequent atrial pacing.
Patients with hypertrophic cardiomyopathy or long-
standing hypertension have abnormal ventricular dia-
stolic function. The apparent increase in muscle stiffness
and associated resistance to passive diastolic filling of
the left ventricle underline the importance of an appro-
priately timed atrial systole in the preservation of ven-
tricular filling in late diastole'37'381. Shefer et a/.'17]
demonstrated striking haemodynamic differences be-
tween ventricular and AV sequential pacing. Loss of
atrial synchrony was associated with a symptomatic fall
in stroke volume. Dritsas et a/.'241 observed that optimiz-
ing the AV delay is more important in patients with
impaired left ventricular diastolic function than in
patients with severely impaired systolic function. There-
fore, efforts should be made to maintain AV synchrony
in patients with abnormal diastolic function, e.g. hyper-
trophic cardiomyopathy, and, thus, an AV sequential
pacemaker should be used.
HAEMODYNAMIC ADVANTAGE OF MAINTAINED AV
SYNCHRONY DURING EXERCISE
Rate-adapted A V delay pacing
Whether a rate-adapted or a fixed short AV delay
improves haemodynamic performance during exer-
cise remains controversial (Table 2). A significant
effect128'42431 or no effect at all'44^61 on haemodynamics
or clinical parameters has been reported in patients with
a shorter AV delay during exercise than at rest. The
differing results might be explained by different study
designs, especially when exercise capacity was only sub-
maximal or maximal. Sheppard et a/.[47] investigated
patients with complete AV block and found that at
lower exercise levels cardiac haemodynamics did not
differ when pacemakers were programmed to rate-
adapted or fixed AV delays. At peak exercise, however,
patients randomized to a rate-adapted AV delay showed
better cardiac haemodynamics than patients with a fixed
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Table 2 Benefit of an optimized A V delay during exercise
Reference,
year
With benefit
Mehta[2S1, 1989
Leman[42), 1985
Ritter1431, 1989
Without benefit
Lau1441, 1990
Haskell145!, 1989
Rydenf*1, 1988
Parameters
measured
CO
EF, SV
CI, SVl
CO
Exercise
capacity
Exercise
capacity
Method
used
Doppler
RNV
Thermodilution
Doppler
02 uptake
O2 uptake
IxCIIlol fci
AV delay of 75-100 ms preferred to AV
delay of 150-200 ms
AV delay of 100 ms preferred to 150 ms
Rate- adapted AV delay preferred to a
fixed AV delay (150 ms, 200 ms)
Same CO for short (75 ms) and long
150 ms) AV delays
Same exercise capacity for short (66 ms)
and long (168 ms) AV delays
Same exercise capacity for various AV
delays (50, 100, 200, 250 ms)
AV=atrio ventricular, CI = cardiac index, CO = cardiac output, EF=ejection fraction,
RNV = radionuclide ventriculography, SV = stroke volume, SVI = stroke volume index.
AV delay, although the duration of exercise was the
same. The atrial contribution to ventricular filling is
minimized or absent depending on the sensing of the
P-wave, i.e. at higher heart rates induced by heavier
exercise the P-wave coincides with the previous T-wave
and, thus, eliminates the atrial 'kick'. Irrespective of the
haemodynamic benefit, a rate-adapted AV delay seems
to be preferable to a fixed AV delay which allows the
upper tracking rate to increase with less limiting upper
rate behaviour.
Dual chamber versus rate-adapted ventricular pacing
The same controversy exists whether dual chamber
pacing is better than rate-responsive ventricular pacing.
While some investigators'8'44'48"501 demonstrated a slight
but significant improvement in cardiac output during
exercise due to AV synchrony, others123-4651"541 entirely
attributed this improvement to the heart rate increase
and not to AV synchrony (Table 3). This discrepancy is
probably a matter of different pacemaker settings, pos-
ture, work loads, study populations and underlying
heart disease. Lemke et a/.'551 found in patients with
isolated sick sinus node disease a more pronounced
increase in oxygen consumption and work capacity
during rate-responsive dual chamber pacing than during
rate-responsive ventricular pacing. In patients with a
high degree of AV block the differences between the
pacing modes were not significant. Furthermore, the
distinction was rarely made between patients with nor-
mal and impaired left ventricular function. French et al.
demonstrated'231 in patients with reduced left ventricular
function, that during exercise physiological AV syn-
chrony is less important that rate-responsiveness. Dur-
ing exercise the shortening of diastole unfavourably
adds to high left ventricular filling pressures in the
diseased heart; thus, the beneficial effects of AV syn-
chrony may be even less. In a population with normal
left ventricular function Ausubel et a/.'561 showed that
atrial synchronous pacing results in enhanced ventricu-
lar filling and spared contractile reserves when compared
with rate-responsive ventricular pacing, but heart rate,
blood pressure and work load remained the same during
exercise in the two pacing modes. In our own study1501
none of the patients with normal or with impaired left
ventricular function benefited clinically from a preserved
AV synchrony; however, patients with normal left ven-
tricular function and dual chamber pacing showed a
higher oxygen consumption. Some of the discrepancies
between the quoted studies may be accounted for by
differences in exercise, which was either moderate or
symptom-limited. Linde-Edelstam et al.[S7] found that
the relative contribution of atrial systole to ventricular
filling is most important at rest, and that during exercise
the relative contribution of atrial systole diminished
concomitantly with a rise in mitral blood flow velocity.
Thus, increasing kinetic energy of blood flow reduces
atrial contribution to left ventricular filling.
QUALITY OF LIFE AND MAINTAINED AV SYNCHRONY
The effects of pacing mode on quality of life has been
less studied. While Oldroyd et alPi] and Bubien and
Kay1591 failed to find any difference in symptoms be-
tween dual chamber and rate-responsive ventricular
pacing, others'60^1 demonstrated a better quality of life
with dual chamber pacing. Linde-Edelstam et a/.'611
explained the patients' preference for dual chamber
pacing in comparison with rate-responsive ventricular
pacing by a significant reduction in cardiovascular
symptoms, improved self-perceived health, enhanced
physical ability and psychological well-being. However,
mean heart rate during the active hours of the day was
higher with dual chamber pacing than with rate-
responsive ventricular pacing. Menozzi et a/.'62' investi-
gated 14 patients with high degree AV block and found
that the improvement in quality of life was reflected by
the haemodynamic advantages of atrial synchronization.
Five of these 14 patients did not tolerate rate-responsive
ventricular pacing and were switched to dual chamber
pacing because of intolerable symptoms, such as signs of
1434 J. Frielingsdorf et al.
Table 3 Importance of pacing mode during exercise: VVIR versus A V synchronous (DDD, VDD)
pacing
Reference,
year
Parameters
measured
Method
used Remarks
AV with benefit
Karlof81, 1975
Lau1*41, 1990
Lemke1481, 1990
Landzberg1491, 1990
Frielingsdorf501, 1993
AV without benefit
French1231, 1988
Ryden1**1, 1988
Fnehngsdorf501, 1993
Kristensson1"1, 1985
Pehrson1521, 1983
Fananapazir1"1, 1983
I_inde-Edelstam[M1, 1992
CO
CO
SV, ANP
Exercise
capacity
Exercise
capacity
Exercise
capacity
Exercise
capacity
Exercise
capacity
SV, CO
Exercise
capacity
Exercise
capacity
Exercise
capacity
SV, CO
CVC, Fick —
Doppler
CVC, Fick ANP levels were equal
Treadmill (time)
O2 uptake patients with normal EF
02 uptake
O2 uptake
O2 uptake
Dye dilution
Bicycle (Watt)
Treadmill (time)
O2 uptake
CVC, Fick
Patients with reduced EF
Patients with reduced EF
Epinephrine and norepinephnne
levels were equal
ANP=atrial natriuretic peptide, AV=atnoventncular, CO = cardiac output, CVC = central venous
catheter, DDD = dual chamber pacing, SV = stroke volume, VDD = atrial triggered ventricular
pacing, W I R = rate-adapated ventricular pacing.
congestive heart failure and palpitations. These five
patients were compared to nine patients who did not
require the change to dual chamber pacing. The five
patients were characterized by a lower incidence of
organic heart disease and smaller echocardiographic
chamber diameters. Sulke et a/.'631 demonstrated that
patients who preferred rate-responsive dual chamber
pacing but felt that rate-responsive ventricular pacing
was least acceptable had greater increases in stroke
volume when paced in dual chamber mode than in the
ventricular inhibited mode. Five out of 22 patients
demanded early crossover because of intolerable symp-
toms, such as dyspnoea, dizziness and palpitations.
Mitsuoka et a/.164' who investigated both patients with
the sick sinus syndrome and retrograde atnoventncular
conduction and those with high degree AV block,
demonstrated beneficial effects on symptoms of dual
chamber pacing compared with ventricular pacing.
The weakness of most studies which deal with quality
of life is that AV delay is not appropriately timed and
the programming of rate-responsive parameters is not
optimized. A programmed activity sensor that is too
sensitive with inappropriately high heart rates has been
demonstrated to be poorly tolerated by patients'651.
Sulke et a/.'661 reported that most patients who were
satisfied with long-term W I pacing benefited from the
upgrading of ventricular to dual chamber pacing; this
suggests there is a 'subclinical' pacemaker syndrome.
The disadvantage of ventricular pacing is related to the
absence of— or random occurrence of — atrial contri-
bution to ventricular filling; thus, stroke volume is
especially decreased at rest. A further unfavourable
factor is the presence of retrograde atrial contraction
(VA conduction) which occurs simultaneously or just
after the paced ventricular contraction. The lack of
coordination between atrial and ventricular contraction
may provoke palpitations and hypotension with symp-
toms of dizziness which have been described as the
'pacemaker syndrome'1671. The atrial contractions
against closed AV valves, which induce retrograde atrial
emptying and atrial distension, may initiate unfavour-
able peripheral autonomic reflexes168 70] or blunt the
baroreceptor reflex; cardiac output sometimes decreases
to levels lower than during unpaced sinus bradycardia.
Patients with the sick sinus syndrome are particularly
prone to develop the pacemaker syndrome because they
often have preserved AV conduction. Up to 90% of such
patients may have a VA conduction'711, whereas the
cumulative incidence of the pacemaker syndrome has
been reported as high as 7% and as low as 0-5%'72-73].
The haemodynamic compromise observed with VA con-
duction appears disproportionately greater than would
be expected if it were the mere consequence of the loss of
atrial transport. VA conduction may cause atrial con-
traction to coincide with a closed AV valve and produce
pronounced atrial distention. Nishimura et a/.'741 dem-
onstrated that nearly all patients with symptomatic
ventricular-inhibited pacing-induced hypotension had
intact VA conduction. Another entity is the 'AAIR
pacemaker syndrome*'75761. Patients chronically paced
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Table 4 Alrial fibrillation, chronic heart failure and mortality m ventricular ( VVI) versus atnal based pacing (AAI, A V synchronous) in
patients with the sick sinus node syndrome or AV block
Reference,
year
Sick simis node
Stangl'771, 1990
Feuer*781, 1989
Rosenqvist1801, 1986
Markewitz1811, 1986
Santini'831, 1990
Rosenqvist1841, 1988
Sasaki1851, 1991
Zanim[M1, 1989
Sasaki1871, 1988
Andersen1881, 1993
Albert1931, 1987
Mean**
AV block
Alpert1941, 1986
Linde1951, 1992
Mean
Follow-up
(months)
53
44
24
32
54
48
62
40
35
•
60
60
65
Patients (n)
W l
112
70
79
87
125
79
34
57
25
115
79
132
74
AAI/AV
110
61
89
136
214
89
41
53
24
110
49
48
74
W l
19
25
30
30
47
47
44
18
36
19
—
28
—
—
AF (%)
AAI/AV
6
11
4
7
7
7
17
4
0
10
7
—
—
W l
23
37
21
5
28
—
24
—
—
CHF (%)
AAI/AV
7
15
2
2
4
—
6
—
—
Mortality (%)
W l
31
10
—
30
23
24
18
24
13
26
24
34
36
35
AAI/AV
19
6
—
14
8
0
9
13
11
16
12
15
32
25
AAI = atnal pacing, AV = atrioventricular synchronous pacing, AF = atrial fibrillation, atnal flutter, CHF = congestive heart failure, *no
data; "study no. 80 was excluded because it was amalgamated with no. 84
in the rate-responsive atrial mode may have a paradoxi-
cally increased stimulus-R interval, producing P waves
occurring immediately after, or even within, the R wave
of the preceding cycle which nullifies the haemodynamic
contribution of the atrial systole. This may result in a
limitation of the exercise capacity.
MORBIDITY AND MORTALITY WITH AND WITHOUT
MAINTAINED AV SYNCHRONY
Morbidity: Atrial fibrillation, thromboembolic complica-
tions and chronic heart failure (Table 4, Fig. 1)
In patients with a sick sinus node disease the incidence
of a new onset of atrial fibrillation, with its associated
CHF
n = 402
Mortality
n = 1316
Figure I Percentage of chronic atrial fibrillation/flutter (AF),
chronic heart failure (CHF) and mortality with ventricular (Wl,
~) and atrial based (AAI/AV, • ) pacing, reported in patients with
the sick sinus node disease (average of Table 4). The percentage of
patients is given on top of each bar, n = total number of patients.
thromboembolic complications, is higher with ventricu-
lar stimulation (VVI) than with a stimulation in which
AV synchrony is preserved (atrial based pacing: AAI,
VDD, DDD). The review of several studies177"881 reveals
an incidence of atrial fibrillation of 18-47% among
patients with ventricular stimulation and 0-17% of all
patients with AV synchronous stimulation. A literature
review by Sutton and Kenny1891 demonstrated over a
period of 31 months a 12-3% incidence of thrombo-
embolic complications in patients with ventricular
stimulation (n = 347) in comparison with 1-6% (/)<0001)
with atrial stimulation (n = 321). The incidence of
chronic heart failure for both ventricular and AV syn-
chronous pacing resembles the corresponding incidence
of atrial fibrillation'84"871 for these pacing modes. There
are no data available on patients with high degree AV
block and pacing modality as regards atrial fibrillation
or chronic heart failure.
Mortality (Table 4, Fig. 1)
The 5-year survival rate of patients with a sick sinus
node disease is, on the one hand, comparable with
the mortality of patients with high degree AV block,
and on the other with mortality of the non-paced
population'90"921. The prognosis for survival is related
to the underlying heart disease and left ventricular
function. The influence of pacing modality on survival
has been addressed, in particular, in patients with
sinus node disease and it is the object of only a few
studies'778188'931. Rosenqvist et al.m reported a mortal-
ity of 23% in the population with ventricular stimulation
in comparison with the significantly lower mortality of
8% in the atrial paced population. Alpert et a/.'931
demonstrated a lower survival rate in patients with
chronic heart failure — but not in patients without heart
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failure — and ventricular stimulation than in patients
with dual chamber stimulation. In patients with high
degree AV block, AV synchronous pacing was prefer-
able to ventricular pacing only when congestive heart
failure was present'94'951.
The quoted studies demonstrate the superiority of AV
synchronous pacing to ventricular pacing. However,
some critical remarks are necessary: the conclusions of
these studies only apply to paced patients with a sick
sinus node disease. Patients with high degree AV block
were not sufficiently investigated. Apart from two excep-
tions185'881, all data originate from retrospective rather
than randomized prospective trials. In some studies the
study population was small and patients with fixed-rate
ventricular stimulation served as controls. There are
only limited data available which compare rate-
responsive ventricular with AV synchronous stimula-
tion. Van Erckelens et a/.'821 showed a similar incidence
of atrial fibrillation with rate-responsive ventricular and
dual chamber pacing.
In patients with the sick sinus node disease and
without AV conduction abnormalities, atrial inhibited
pacing may be an alternative to dual chamber pacing. A
study by Elshot et a/.'961 with a follow-up of 12 years
revealed an annual incidence of permanent atrial fibril-
lation of 1% which is comparable to the results of other
recent investigations'97'981. In the same study'961 the
annual incidence of chronic atrial fibrillation in atrial
pacing was reported from several other studies to range
between 0-4 and 3-3%, compared to 4-3 and 11-7% in
ventricular pacing; the reported annual mortality rate
was between 0-5 and 4-8% in atrial pacing compared to
3-5 and 9-3% in ventricular pacing. Chronic atrial fibril-
lation mainly develops in patients with the brady-tachy
syndrome1961 or in patients with a long history of epi-
sodes of pre-implant paroxysmal atrial fibrillation last-
ing more than 1 h[99]. Atrial inhibited pacing in the sick
sinus node disease may be limited by progression of high
degree AV block, but two reviews of 28[89] and 27
studies'1001, respectively, showed a low annual incidence
of AV conduction disturbances ranging between 07
and 3%.
Atrial inhibited pacing might even be superior to dual
chamber pacing, partly due to the prevention of
bradycardia-induced inhomogeneity of atrial refractori-
ness and partly to improved haemodynamics. There is
evidence that atrial pacing may prevent paroxysmal
atrial fibrillation'101'1021. Haemodynamic characteristics
are better with atrial-inhibited pacing compared to dual
chamber pacing1103~1051 which is partly explained by
intrinsic AV conduction'1061 and synchronous ventricu-
lar contraction'107'1081. To our knowledge, there are no
prospective morbidity and mortality studies comparing
atrial inhibited pacing to dual chamber pacing.
COMPLICATIONS AND COSTS
Complications
The implantation of a dual chamber pacemaker is not
associated with a higher rate of complications than that
of a single chamber pacemaker. Whereas the most
frequent complication of ventricular stimulation is the
pacemaker syndrome, the dual chamber pacemaker is
prone to malfunction of atrial sensing and pacemaker-
induced tachycardia. Mueller et a/.'1091 prospectively
analysed 258 patients with single chamber (VVI) and 75
patients with dual chamber pacemakers over a period of
3 years. There was no significant difference in relation to
reintervention (5% of single chamber and 5-3% of dual
chamber pacemakers), lead displacement with reopera-
tion (1% vs 1-3%), infection (0-77% vs 1-33%), muscular
stimulation (3 5% vs 4%) and urgent reprogramming
(9% vs 8%). Goldman et a/."101 showed a higher peri-
operative complication rate in patients with dual cham-
ber pacemakers (6-8%) than in patients with single
chamber pacemakers (2-6%). In the study of Parsonnet
et a/.'1"1 there was a substantially larger incidence of
complications when the implanters performed less than
12 implantations per year, this was particularly true for
the incidence of lead-related complications.
Costs
Over a 12-year period Eagle et a/.'"2' compared the
incremental cost of single and dual chamber pace-
makers. At implantation, the single chamber device
costed US $2503 less than the dual chamber device
($6924 compared with $9427) and after 12 years the cost
difference was $5167 ($11 339 compared with $16 506).
Thus, the difference in cost between single and dual
chamber pacemakers is not simply a reflection of the
initial implantation costs. The cumulative difference in
costs continues to increase with time, and the major
contribution was the more frequent failure rate of dual
chamber generators. In this 12-year frame, a recipient of
a dual chamber pacemaker would anticipate 0-74 gen-
erator replacements compared to 0-46 for single cham-
ber pacemaker recipients. The differences would have
been even greater if patients had survived longer. The
quoted study was published in 1986; thus, as a result of
improved survival in dual chamber generator batteries a
third of the eventual cost difference could be eliminated.
However, one of the major contributors to post-
implantation costs, which remained unchanged over
time, was the more frequent follow-up schedule for
patients with dual chamber devices1"21. In the case of
single chamber ventricular devices, the pacemaker syn-
drome and its resulting need for pacemaker revision to a
dual chamber system accounted for just a small fraction
of total cost1"21. A recent British study1'131, which cov-
ered Northern England, with a population of three
million inhabitants, showed considerable changes in
regional pacing practice. The adoption of the optimal
pacing practice recommended by the British Pacing and
Electrophysiology Groups, e.g. dual chamber instead of
single chamber pacing, would result in a substantial
increase in expenditure. According to these recommen-
dations the annual pacing budget for pacing hardware
would have increased from £333 535 to £647 163 (in-
crease of 94%) for the use of the optimal pacing mode.
But these studies have not taken into account lower
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morbidity and mortality associated with dual chamber
pacing, resulting in a considerable health benefit, thus,
reducing rehospitalizations and costs. There might be a
substantial reduction in costs if atrial pacemakers were
more widely used than dual chamber systems in patients
with a sick sinus node disease. Costs could also be saved
by changing a single chamber atrial pacemaker to either
a ventricular pacemaker (because of chronic atrial fibril-
lation) or to a dual chamber pacemaker (because of
progression of AV conductance disturbances).
Conclusions
The effect of atrial contraction on cardiac function is
complex and depends on different interacting factors,
such as left ventricular systolic and diastolic function,
intra-atrial conduction time as well as atrial size and
contraction. It seems reasonable to conclude that dual
chamber pacing is superior to ventricular pacing, as
regards haemodynamics at rest and quality of life. The
data on optimal pacing during exercise conditions would
require more homogeneous study designs for the deter-
mination of the importance of maintained AV syn-
chrony, such as work loads, optimized AV delays and
study populations. Furthermore, it remains to be deter-
mined whether other groups such as older patients, less
active patients or those with diastolic dysfunction may
especially benefit from AV synchrony. Patients with
pacemakers which maintain AV synchrony seem to have
a lower morbidity and mortality than patients with
single chamber ventricular stimulation, but larger pro-
spective randomized trials are needed to prove or
disprove this hypothesis.
Atrial inhibited pacing is an under-used mode of
cardiac stimulation but still remains the best pacing
mode in many patients with the sick sinus node disease,
whereas dual chamber pacing is the preferred mode in
patients with high degree AV block. Today, single
chamber ventricular pacing is restricted to patients with
chronic atrial fibrillation and brady-arrhythmias.
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